256 related articles for article (PubMed ID: 20348951)
21. IFN-γ and TNF-α-induced GBP-1 inhibits epithelial cell proliferation through suppression of β-catenin/TCF signaling.
Capaldo CT; Beeman N; Hilgarth RS; Nava P; Louis NA; Naschberger E; Stürzl M; Parkos CA; Nusrat A
Mucosal Immunol; 2012 Nov; 5(6):681-90. PubMed ID: 22692453
[TBL] [Abstract][Full Text] [Related]
22. Mixed lineage kinase 3 modulates β-catenin signaling in cancer cells.
Thylur RP; Senthivinayagam S; Campbell EM; Rangasamy V; Thorenoor N; Sondarva G; Mehrotra S; Mishra P; Zook E; Le PT; Rana A; Rana B
J Biol Chem; 2011 Oct; 286(43):37470-82. PubMed ID: 21880738
[TBL] [Abstract][Full Text] [Related]
23. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
[TBL] [Abstract][Full Text] [Related]
24. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
25. A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.
Whitt JD; Li N; Tinsley HN; Chen X; Zhang W; Li Y; Gary BD; Keeton AB; Xi Y; Abadi AH; Grizzle WE; Piazza GA
Cancer Prev Res (Phila); 2012 Jun; 5(6):822-33. PubMed ID: 22556201
[TBL] [Abstract][Full Text] [Related]
26. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
[TBL] [Abstract][Full Text] [Related]
27. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity.
Hoogeboom D; Essers MA; Polderman PE; Voets E; Smits LM; Burgering BM
J Biol Chem; 2008 Apr; 283(14):9224-30. PubMed ID: 18250171
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic acid activates β-catenin/T cell factor signaling, which contributes to the suppression of apoptosis in H19-7 cells.
Sun Y; Kim NH; Ji L; Kim SH; Lee J; Rhee HJ
Mol Med Rep; 2013 Dec; 8(6):1729-33. PubMed ID: 24145616
[TBL] [Abstract][Full Text] [Related]
29. Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity.
Guo RJ; Huang E; Ezaki T; Patel N; Sinclair K; Wu J; Klein P; Suh ER; Lynch JP
J Biol Chem; 2004 Aug; 279(35):36865-75. PubMed ID: 15215241
[TBL] [Abstract][Full Text] [Related]
30. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways.
Rice PL; Peters SL; Beard KS; Ahnen DJ
Mol Cancer Ther; 2006 Mar; 5(3):746-54. PubMed ID: 16546990
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
Pálmer HG; González-Sancho JM; Espada J; Berciano MT; Puig I; Baulida J; Quintanilla M; Cano A; de Herreros AG; Lafarga M; Muñoz A
J Cell Biol; 2001 Jul; 154(2):369-87. PubMed ID: 11470825
[TBL] [Abstract][Full Text] [Related]
32. cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment.
Browning DD; Kwon IK; Wang R
Future Med Chem; 2010 Jan; 2(1):65-80. PubMed ID: 21426046
[TBL] [Abstract][Full Text] [Related]
33. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
34. RNA-binding motif protein 5 negatively regulates the activity of Wnt/β-catenin signaling in cigarette smoke-induced alveolar epithelial injury.
Hao YQ; Su ZZ; Lv XJ; Li P; Gao P; Wang C; Bai Y; Zhang J
Oncol Rep; 2015 May; 33(5):2438-44. PubMed ID: 25738917
[TBL] [Abstract][Full Text] [Related]
35. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of beta-catenin/Tcf signaling by flavonoids.
Park S; Choi J
J Cell Biochem; 2010 Aug; 110(6):1376-85. PubMed ID: 20564233
[TBL] [Abstract][Full Text] [Related]
37. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.
Park CH; Chang JY; Hahm ER; Park S; Kim HK; Yang CH
Biochem Biophys Res Commun; 2005 Mar; 328(1):227-34. PubMed ID: 15670774
[TBL] [Abstract][Full Text] [Related]
38. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic activation of beta-catenin and T-cell-specific transcription factor signaling in vascular endothelium regulates fibronectin expression.
Gelfand BD; Meller J; Pryor AW; Kahn M; Bortz PD; Wamhoff BR; Blackman BR
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1625-33. PubMed ID: 21527747
[TBL] [Abstract][Full Text] [Related]
40. Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling.
Du Q; Park KS; Guo Z; He P; Nagashima M; Shao L; Sahai R; Geller DA; Hussain SP
Cancer Res; 2006 Jul; 66(14):7024-31. PubMed ID: 16849547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
